GSK-3145095

Investigational

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C20H17F2N5O2
Molecular Weight	397.3781
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

FC1=CC(F)=C2NC(=O)[C@H](CCC2=C1)NC(=O)C3=NN=C(CC4=CC=CC=C4)N3

InChI

InChIKey=ATQAGKAMBISZQM-HNNXBMFYSA-N

InChI=1S/C20H17F2N5O2/c21-13-9-12-6-7-15(19(28)25-17(12)14(22)10-13)23-20(29)18-24-16(26-27-18)8-11-4-2-1-3-5-11/h1-5,9-10,15H,6-8H2,(H,23,29)(H,25,28)(H,24,26,27)/t15-/m0/s1

HIDE SMILES / InChI

Approval Year

Name

Type

Language

GSK-3145095

Code

English

(S)-5-BENZYL-N-(7,9-DIFLUORO-2-OXO-2,3,4,5-TETRAHYDRO-1HBENZO(B)AZEPIN-3-YL)-1H-1,2,4-TRIAZOLE-3-CARBOXAMIDE (7,7-DIMETHYL-2- OXOBICYCLO(2.2.1)HEPTAN-1-YL)

Common Name

English

Code System Code Type Description

FDA UNII

B4D3WPS7JY

Created by admin on Sat Dec 16 14:18:57 GMT 2023 , Edited by admin on Sat Dec 16 14:18:57 GMT 2023

PRIMARY

PUBCHEM

118557502

Created by admin on Sat Dec 16 14:18:57 GMT 2023 , Edited by admin on Sat Dec 16 14:18:57 GMT 2023

PRIMARY

NCI_THESAURUS

C156737

Created by admin on Sat Dec 16 14:18:57 GMT 2023 , Edited by admin on Sat Dec 16 14:18:57 GMT 2023

PRIMARY

CAS

1622849-43-7

Created by admin on Sat Dec 16 14:18:57 GMT 2023 , Edited by admin on Sat Dec 16 14:18:57 GMT 2023

PRIMARY

ACTIVE MOIETY


					B4D3WPS7JY

GSK-3145095